Tolypothrix Dichloromethane Ethylacetate fraction (TDEF) inhibits cisplatin resistance H357 cell through PI3K/AKT/beta-catenin pathway.
Article in American Journal of Cancer Research (January 2024)
The most recent citing publications are shown below. View all 16 publications that cite this research output on Dimensions.
Article in American Journal of Cancer Research (January 2024)
Article in International Journal of Surgery (November 2023)
Article in Molecular Therapy — Oncolytics (July 2023)